The involvement of spinal bovine adrenal medulla 22-like peptide, the proenkephalin derivative, in modulation of nociceptive processing.
Bovine adrenal medulla 22 (BAM22), one of the cleavage products of proenkephalin A, possesses high affinity for opioid receptors and sensory neuron-specific receptor (SNSR). The present study was designed to examine the expression of BAM22 in the spinal cord and dorsal root ganglion (DRG) of naive rats as well as in a model of inflammation. BAM22-like immunoreactivity (BAM22-IR) was expressed in fibers in the spinal cord, with high density seen in lamina I in naïve rats. The expression of BAM22-IR in the superficial laminae was greatly reduced following dorsal rhizotomy. BAM22-IR was also located in 19% of DRG cells, mainly in the small- and medium-sized subpopulations. Following injection of complete Freund's adjuvant (CFA) in the hindpaw, the expression of BAM22-IR in the superficial laminae of the spinal cord and small-sized DRG neurons on the ipsilateral side was markedly increased. Double labeling showed that the Fos-positive nucleus was surrounded by BAM22-IR cytoplasm in the spinal dorsal horn neurons or closely associated with BAM22-IR fibers in the superficial laminae. Furthermore, CFA-induced mechanical allodynia in the inflamed paw was potentiated by intrathecal administration of anti-BAM22 antibody. Together, these results demonstrate for the first time that BAM22-like peptide is mainly located in the superficial laminae of the spinal cord and mostly originates from nociceptive DRG neurons. BAM22 could thus act as a ligand for presynaptic opioid receptors and SNSR. Our study also provides evidence suggesting that BAM22 plays a role in the modulation of nociceptive processing at the spinal level under normal and inflammatory conditions.
Cai
Meifang
M
Key Provincial Laboratory of Developmental Biology and Neuroscience, College of Life Sciences, Fujian Normal University, Fuzhou, People's Republic of China, 350108.
Chen
Tingjun
T
Quirion
Rémi
R
Hong
Yanguo
Y
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage; D001522:Behavior, Animal; D004195:Disease Models, Animal; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives* / Q000276:immunology / Q000378:metabolism; D005620:Freund's Adjuvant; D007839:Functional Laterality; D005727:Ganglia, Spinal / Q000166:cytology / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology; D008297:Male; D009474:Neurons / Q000378:metabolism; D016761:Oncogene Proteins v-fos / Q000378:metabolism; D010146:Pain / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology*; D010147:Pain Measurement; D011498:Protein Precursors / Q000276:immunology / Q000378:metabolism*; D051381:Rats; D019051:Rhizotomy / Q000379:methods; D013116:Spinal Cord / Q000378:metabolism*; D013119:Spinal Cord Injuries
D000906:Antibodies; D016761:Oncogene Proteins v-fos; D011498:Protein Precursors; D004744:Enkephalin, Methionine; C028837:BAM 22P; D005620:Freund's Adjuvant